Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Shuttle Pharmaceuticals Holdings, Inc. entered into Placement Agency Agreement with E.F. Hutton & Co. valued at Placement agency agreement on a reasonable best-efforts basis, with cash fee of 4.0% of gross procee (effective 2026-03-05).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- E.F. Hutton & Co.
- Value
- Placement agency agreement on a reasonable best-efforts basis, with cash fee of 4.0% of gross procee
- Effective
- 2026-03-05
Exact text from the filing
On March 5, 2026, the Company entered into a Placement Agency Agreement (the “Placement Agency Agreement”) with E.F. Hutton & Co., as placement agent (the “Placement Agent”), pursuant to which the Placement Agent agreed to act as the Company’s exclusive placement agent in connection with the Offering.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Shuttle Pharmaceuticals Holdings, Inc. entered into Securities Purchase Agreement with the purchasers named therein valued at The Company agreed to issue and sell 2,238,800 shares of common stock and pre-funded warrants to pur (effective 2026-03-05).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- the purchasers named therein
- Value
- The Company agreed to issue and sell 2,238,800 shares of common stock and pre-funded warrants to pur
- Effective
- 2026-03-05
Exact text from the filing
In connection with the Offering, the Company entered into a Securities Purchase Agreement, dated March 5, 2026 (the “Purchase Agreement”), by and among the Company and the purchasers named therein, pursuant to which the Company agreed to issue and sell the shares of Common Stock and Pre-Funded Warrants.
View on SEC.gov